Posted in Pipeline BBOT shakes up leadership as RAS competitors get more visibility April 23, 2026 BioSpace Chief Scientific Officer Pedro Beltran will succeed Eli Wallace as CEO of BridgeBio Oncology Therapeutics, as the board eyes a busy period of clinical advancement in the RAS oncology space. PipelineOncologyRead full story